ClariVest Asset Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

ClariVest Asset Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-44,610	Closed	-$2.41M	–	806
2017 Q4	$2.41M	Buy	44,610 +44,591	+234,689%	+$2.44M	0.04%	317
2017 Q3	$1K	Hold	19	–	–	﹤0.01%	638
2017 Q2	$1K	Buy	+19	New	+$1.08K	﹤0.01%	652

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

ClariVest Asset Management's BIVV Position: Q1 2018 in Review

ClariVest Asset Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 44,610 shares — an estimated $2.41M sold.

ClariVest Asset Management first reported a position in BIVV in Q2 2017 and held it in 3 quarters. The position peaked at $2.41M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

ClariVest Asset Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
ClariVest Asset Management sold 44,610 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $2.41M.
ClariVest Asset Management first reported a position in Bioverativ Inc. Common Stock in Q2 2017 and held it in 3 quarters.
ClariVest Asset Management's Bioverativ Inc. Common Stock position peaked at $2.41M in Q4 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on ClariVest Asset Management's 13F filing for Q1 2018, filed 8 May 2018.